Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://henrippxs909127.ampedpages.com/retatrutide-australia-a-new-hope-for-losing-weight-69874192